We specialize in Phase II-IV clinical trials for a variety of psychiatric disorders.
Alea Research takes pride in consistently delivering high quality conduct of clinical trials for our patients and pharmaceutical sponsors. We specialize in Phase II-IV clinical trials for a variety of psychiatric and other medical disorders. Our experienced staff, fully equipped facility, and proficiency in collaborating with pharmaceutical companies makes Alea the ideal site for research trials.
The Alea Research team is comprised of a variety of clinical research professionals with extensive experience in the industry. Two board certified psychiatrists, physician assistant, cognitive testing staff, regulatory and quality assurance professionals, ACRP certified research assistants, and medical assistants all help the Alea team thrive. An established internal quality control program ensures ongoing adequate staff training and proper conduct of clinical trial procedures. All patient ratings and clinical evaluations are performed by qualified personnel.
Alea Research complies with standards in equipment, including: double-locked, limited access drug storage room, a CLIA-waived processing laboratory with a refrigerated centrifuge, and a -20-degree freezer. We perform on-site vitals and maintain relationships with nearby facilities for PET, CT, or MRI scans, in addition to other procedures that may be necessary in clinical trials. Regulatory submissions are done with a central IRB.
The office is conveniently located in downtown Phoenix, with easy access to the airport and public transportation. We offer DSL and wireless internet connections for CRA visits and maintain a comfortable office environment for patients, staff, and CRAs.
Alea is a preferred research facility dedicated to conducting high quality clinical trials through adherence to GCP and ICH standards, following best medical practice standards, and providing compassionate, involved investigators and staff. We are committed to maintaining our reputation for excellence in clinical trials through enrolling the right patients and efficiently providing sponsors with clean, quality data.